ReP USP - Resultado da busca

Artigo de periodico
Multiparameter optimization of Trypanocidal cruzain inhibitors with in vivo activity and favorable pharmacokinetics (2022)
Pauli, Ivani; Rezende Junior, Celso de Oliveira ; Slafer, Brian W.; Dessoy, Marco A.; Souza, Mariana Laureano de ; Ferreira, Leonardo Luiz Gomes ; Adjanohun, Abraham L. M.; Ferreira, Rafaela S.; Magalhães, Luma Godoy; Andricopulo, Renata Krogh; Duarte, Simone Michelan ; Del Pintor, Ricardo Vaz; Silva, Fernando B. R. da; Cruz, Fabio C.; Dias, Luiz C.; Andricopulo, Adriano Defini
Source: Frontiers in Pharmacology. Unidade: IFSC
Subjects: DOENÇA DE CHAGAS, TRYPANOSOMA CRUZI, QUÍMICA MÉDICA, MODELAGEM MOLECULAR, PLANEJAMENTO DE FÁRMACOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
PAULI, Ivani et al. Multiparameter optimization of Trypanocidal cruzain inhibitors with in vivo activity and favorable pharmacokinetics. Frontiers in Pharmacology, v. 12, n. Ja 2022, p. 774069-1-774069-21 + supplementary material, 2022Tradução . . Disponível em: https://doi.org/10.3389/fphar.2021.774069. Acesso em: 13 jul. 2024.
APA
Pauli, I., Rezende Junior, C. de O., Slafer, B. W., Dessoy, M. A., Souza, M. L. de, Ferreira, L. L. G., et al. (2022). Multiparameter optimization of Trypanocidal cruzain inhibitors with in vivo activity and favorable pharmacokinetics. Frontiers in Pharmacology, 12( Ja 2022), 774069-1-774069-21 + supplementary material. doi:10.3389/fphar.2021.774069
NLM
Pauli I, Rezende Junior C de O, Slafer BW, Dessoy MA, Souza ML de, Ferreira LLG, Adjanohun ALM, Ferreira RS, Magalhães LG, Andricopulo RK, Duarte SM, Del Pintor RV, Silva FBR da, Cruz FC, Dias LC, Andricopulo AD. Multiparameter optimization of Trypanocidal cruzain inhibitors with in vivo activity and favorable pharmacokinetics [Internet]. Frontiers in Pharmacology. 2022 ; 12( Ja 2022): 774069-1-774069-21 + supplementary material.[citado 2024 jul. 13 ] Available from: https://doi.org/10.3389/fphar.2021.774069
Vancouver
Pauli I, Rezende Junior C de O, Slafer BW, Dessoy MA, Souza ML de, Ferreira LLG, Adjanohun ALM, Ferreira RS, Magalhães LG, Andricopulo RK, Duarte SM, Del Pintor RV, Silva FBR da, Cruz FC, Dias LC, Andricopulo AD. Multiparameter optimization of Trypanocidal cruzain inhibitors with in vivo activity and favorable pharmacokinetics [Internet]. Frontiers in Pharmacology. 2022 ; 12( Ja 2022): 774069-1-774069-21 + supplementary material.[citado 2024 jul. 13 ] Available from: https://doi.org/10.3389/fphar.2021.774069
Artigo de periodico
Discovery of potent, reversible, and competitive cruzain inhibitors with trypanocidal activity: a structure-based drug design approach (2020)
Souza, Mariana Laureano de; Rezende Junior, Celso de Oliveira; Ferreira, Rafaela S. ; Chávez, Rocio Marisol Espinoza; Ferreira, Leonardo Luiz Gomes; Slafer, Brian W.; Magalhães, Luma Godoy; Andricopulo, Renata Krogh; Oliva, Glaucius ; Cruz, Fabio Cardoso; Dias, Luiz Carlos; Andricopulo, Adriano Defini
Source: Journal of Chemical Information and Modeling. Unidade: IFSC
Subjects: TRIPANOSSOMICIDAS, PLANEJAMENTO DE FÁRMACOS, INIBIDORES QUÍMICOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SOUZA, Mariana Laureano de et al. Discovery of potent, reversible, and competitive cruzain inhibitors with trypanocidal activity: a structure-based drug design approach. Journal of Chemical Information and Modeling, v. 60, n. 2, p. 1028-1041, 2020Tradução . . Disponível em: https://doi.org/10.1021/acs.jcim.9b00802. Acesso em: 13 jul. 2024.
APA
Souza, M. L. de, Rezende Junior, C. de O., Ferreira, R. S., Chávez, R. M. E., Ferreira, L. L. G., Slafer, B. W., et al. (2020). Discovery of potent, reversible, and competitive cruzain inhibitors with trypanocidal activity: a structure-based drug design approach. Journal of Chemical Information and Modeling, 60( 2), 1028-1041. doi:10.1021/acs.jcim.9b00802
NLM
Souza ML de, Rezende Junior C de O, Ferreira RS, Chávez RME, Ferreira LLG, Slafer BW, Magalhães LG, Andricopulo RK, Oliva G, Cruz FC, Dias LC, Andricopulo AD. Discovery of potent, reversible, and competitive cruzain inhibitors with trypanocidal activity: a structure-based drug design approach [Internet]. Journal of Chemical Information and Modeling. 2020 ; 60( 2): 1028-1041.[citado 2024 jul. 13 ] Available from: https://doi.org/10.1021/acs.jcim.9b00802
Vancouver
Souza ML de, Rezende Junior C de O, Ferreira RS, Chávez RME, Ferreira LLG, Slafer BW, Magalhães LG, Andricopulo RK, Oliva G, Cruz FC, Dias LC, Andricopulo AD. Discovery of potent, reversible, and competitive cruzain inhibitors with trypanocidal activity: a structure-based drug design approach [Internet]. Journal of Chemical Information and Modeling. 2020 ; 60( 2): 1028-1041.[citado 2024 jul. 13 ] Available from: https://doi.org/10.1021/acs.jcim.9b00802
Trabalho de evento-resumo
Antitrypanosomal aminobenzimidazoles: hit to lead expansion of new chemical entities against Trypanosoma cruzi and Leishmania infantum (2019)
Ferreira, R. A. A.; Oliveira Junior, C. R.; Martinez, P. G.; Soares, B. M.; Koovits, P.; Duarte, Simone Michelan; Andricopulo, Renata Krogh; Ferreira, Leonardo Luiz Gomes; Chelucci, Rafael Consolin; Magalhães, Luma Godoy; Andricopulo, Adriano Defini ; Mowbray, C. E.; Kratz, J. M.; Dias, L. C.
Source: Anais eletrônicos. Conference titles: Brazilian Symposium on Medicinal Chemistry - BrazMedChem. Unidade: IFSC
Subjects: TRYPANOSOMA CRUZI, LEISHMANIA INFANTUM, PLANEJAMENTO DE FÁRMACOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
FERREIRA, R. A. A. et al. Antitrypanosomal aminobenzimidazoles: hit to lead expansion of new chemical entities against Trypanosoma cruzi and Leishmania infantum. 2019, Anais.. Campinas: Galoá, 2019. Disponível em: https://proceedings.science/p/107147. Acesso em: 13 jul. 2024.
APA
Ferreira, R. A. A., Oliveira Junior, C. R., Martinez, P. G., Soares, B. M., Koovits, P., Duarte, S. M., et al. (2019). Antitrypanosomal aminobenzimidazoles: hit to lead expansion of new chemical entities against Trypanosoma cruzi and Leishmania infantum. In Anais eletrônicos. Campinas: Galoá. Recuperado de https://proceedings.science/p/107147
NLM
Ferreira RAA, Oliveira Junior CR, Martinez PG, Soares BM, Koovits P, Duarte SM, Andricopulo RK, Ferreira LLG, Chelucci RC, Magalhães LG, Andricopulo AD, Mowbray CE, Kratz JM, Dias LC. Antitrypanosomal aminobenzimidazoles: hit to lead expansion of new chemical entities against Trypanosoma cruzi and Leishmania infantum [Internet]. Anais eletrônicos. 2019 ;[citado 2024 jul. 13 ] Available from: https://proceedings.science/p/107147
Vancouver
Ferreira RAA, Oliveira Junior CR, Martinez PG, Soares BM, Koovits P, Duarte SM, Andricopulo RK, Ferreira LLG, Chelucci RC, Magalhães LG, Andricopulo AD, Mowbray CE, Kratz JM, Dias LC. Antitrypanosomal aminobenzimidazoles: hit to lead expansion of new chemical entities against Trypanosoma cruzi and Leishmania infantum [Internet]. Anais eletrônicos. 2019 ;[citado 2024 jul. 13 ] Available from: https://proceedings.science/p/107147
Artigo de periodico
Structure-based and molecular modeling studies for the discovery of cyclic imides as reversible cruzain inhibitors with potent anti-Trypanosoma cruzi activity (2019)
Ferreira, Rafael A. A.; Pauli, Ivani; Sampaio, Thiago S.; Souza, Mariana Laureano de; Ferreira, Leonardo Luiz Gomes; Magalhães, Luma Godoy; Rezende Junior, Celso O.; Ferreira, Rafaela S.; Andricopulo, Renata Krogh; Dias, Luiz C.; Andricopulo, Adriano Defini
Source: Frontiers in Chemistry. Unidade: IFSC
Subjects: DOENÇA DE CHAGAS, TRYPANOSOMA CRUZI, PLANEJAMENTO DE FÁRMACOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
FERREIRA, Rafael A. A. et al. Structure-based and molecular modeling studies for the discovery of cyclic imides as reversible cruzain inhibitors with potent anti-Trypanosoma cruzi activity. Frontiers in Chemistry, v. No 2019, p. 798-1-798-21, 2019Tradução . . Disponível em: https://doi.org/10.3389/fchem.2019.00798. Acesso em: 13 jul. 2024.
APA
Ferreira, R. A. A., Pauli, I., Sampaio, T. S., Souza, M. L. de, Ferreira, L. L. G., Magalhães, L. G., et al. (2019). Structure-based and molecular modeling studies for the discovery of cyclic imides as reversible cruzain inhibitors with potent anti-Trypanosoma cruzi activity. Frontiers in Chemistry, No 2019, 798-1-798-21. doi:10.3389/fchem.2019.00798
NLM
Ferreira RAA, Pauli I, Sampaio TS, Souza ML de, Ferreira LLG, Magalhães LG, Rezende Junior CO, Ferreira RS, Andricopulo RK, Dias LC, Andricopulo AD. Structure-based and molecular modeling studies for the discovery of cyclic imides as reversible cruzain inhibitors with potent anti-Trypanosoma cruzi activity [Internet]. Frontiers in Chemistry. 2019 ; No 2019 798-1-798-21.[citado 2024 jul. 13 ] Available from: https://doi.org/10.3389/fchem.2019.00798
Vancouver
Ferreira RAA, Pauli I, Sampaio TS, Souza ML de, Ferreira LLG, Magalhães LG, Rezende Junior CO, Ferreira RS, Andricopulo RK, Dias LC, Andricopulo AD. Structure-based and molecular modeling studies for the discovery of cyclic imides as reversible cruzain inhibitors with potent anti-Trypanosoma cruzi activity [Internet]. Frontiers in Chemistry. 2019 ; No 2019 798-1-798-21.[citado 2024 jul. 13 ] Available from: https://doi.org/10.3389/fchem.2019.00798
Trabalho de evento-resumo
Carbamoylimidazoles as potent cruzain inhibitors with in vitro and in vivo trypanocidal activity: a structure-based drug design approach (2019)
Rezende Junior, Celso; Souza, Mariana L.; Chavez, Rocio; Ferreira, Rafaela S.; Slafer, Brian W.; Cruz, Fábio C.; Ferreira, Leonardo Luiz Gomes; Magalhães, Luma Godoy; Andricopulo, Renata Krogh; Oliva, Glaucius ; Andricopulo, Adriano Defini ; Dias, Luiz C.
Source: Anais eletrônicos. Conference titles: Brazilian Symposium on Medicinal Chemistry - BrazMedChem. Unidade: IFSC
Subjects: DOENÇA DE CHAGAS, TRYPANOSOMA CRUZI, PLANEJAMENTO DE FÁRMACOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
REZENDE JUNIOR, Celso et al. Carbamoylimidazoles as potent cruzain inhibitors with in vitro and in vivo trypanocidal activity: a structure-based drug design approach. 2019, Anais.. Campinas: Galoá, 2019. Disponível em: https://proceedings.science/p/107156. Acesso em: 13 jul. 2024.
APA
Rezende Junior, C., Souza, M. L., Chavez, R., Ferreira, R. S., Slafer, B. W., Cruz, F. C., et al. (2019). Carbamoylimidazoles as potent cruzain inhibitors with in vitro and in vivo trypanocidal activity: a structure-based drug design approach. In Anais eletrônicos. Campinas: Galoá. Recuperado de https://proceedings.science/p/107156
NLM
Rezende Junior C, Souza ML, Chavez R, Ferreira RS, Slafer BW, Cruz FC, Ferreira LLG, Magalhães LG, Andricopulo RK, Oliva G, Andricopulo AD, Dias LC. Carbamoylimidazoles as potent cruzain inhibitors with in vitro and in vivo trypanocidal activity: a structure-based drug design approach [Internet]. Anais eletrônicos. 2019 ;[citado 2024 jul. 13 ] Available from: https://proceedings.science/p/107156
Vancouver
Rezende Junior C, Souza ML, Chavez R, Ferreira RS, Slafer BW, Cruz FC, Ferreira LLG, Magalhães LG, Andricopulo RK, Oliva G, Andricopulo AD, Dias LC. Carbamoylimidazoles as potent cruzain inhibitors with in vitro and in vivo trypanocidal activity: a structure-based drug design approach [Internet]. Anais eletrônicos. 2019 ;[citado 2024 jul. 13 ] Available from: https://proceedings.science/p/107156

USP Schools

ReP

Filtros

Authors

USP affiliated authors

Subjects

Grupo de pesquisa

Funding Agencies